Efficacy of ipriflavone in established osteoporosis and long-term safety
β Scribed by D. Agnusdei; L. Bufalino
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 533 KB
- Volume
- 61
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Deferasirox is an oral iron chelator, with a long half-life, that can be given once daily, because it provides a 24-hour chelation. Several phase II trials and a pivotal phase III trial have established that, in transfusion-dependent patients with beta-thalassaemia major, deferasirox has a similar e
## Abstract This subgroup analysis of the 6βmonth, openβlabel Switch to Risperidone Microspheres (StoRMi) trial evaluated longβterm safety and efficacy of a direct conversion to risperidone longβacting injectable (RLAI) in 52 elderly patients (β₯65 years) with psychosis stabilized on oral or depot a